UBS (Lux) Equity Fund - Biotech (USD) P-accRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 30/06/2024 |
|
Annual Returns (GBP) | 30/06/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 30/06 | |
Price Return | 14.59 | -6.58 | 21.38 | 20.76 | -4.75 | 3.24 | -4.28 | 2.75 |
+/- Category | 4.30 | 1.38 | 1.18 | -5.21 | 4.28 | 11.08 | -3.00 | 3.30 |
+/- Category Index | -0.60 | -4.74 | 4.67 | -12.18 | -5.05 | 0.78 | -11.61 | -15.12 |
% Rank in Category | 30 | 52 | 41 | 45 | 52 | 25 | 62 | 49 |
Trailing Returns (GBP) | 15/07/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | -0.12 | -0.45 | 0.17 |
1 Week | 3.62 | -2.18 | 2.64 |
1 Month | 4.77 | 1.92 | 2.87 |
3 Months | 13.83 | 10.96 | 2.27 |
6 Months | 3.70 | 1.90 | -12.45 |
YTD | 5.49 | 3.47 | -12.43 |
1 Year | 15.50 | 5.02 | -20.85 |
3 Years Annualised | 0.59 | 3.86 | -7.95 |
5 Years Annualised | 4.94 | -2.44 | -7.95 |
10 Years Annualised | 8.84 | -1.17 | -3.21 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 30/06/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | -0.90 | 3.68 | - | - |
2023 | -6.62 | -3.83 | 0.46 | 6.11 |
2022 | -7.95 | -0.63 | 14.94 | -1.81 |
2021 | -7.86 | 9.70 | -0.67 | -5.14 |
2020 | -4.26 | 30.37 | -7.87 | 5.01 |
2019 | 14.09 | -0.03 | -6.70 | 14.06 |
|
Advertisement |